The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global GM1 Gangliosidosis Treatment Market Research Report 2025

Global GM1 Gangliosidosis Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1986717

No of Pages : 61

Ask Your Query
Synopsis
GM1 Gangliosidosis is an inherited central nervous system disorder that destroys nerve cells in the spinal cord and brain.
The global GM1 Gangliosidosis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for GM1 Gangliosidosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GM1 Gangliosidosis Treatment.
Report Scope
The GM1 Gangliosidosis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GM1 Gangliosidosis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GM1 Gangliosidosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Axovant Gene Therapies Ltd
Passage Bio and Lysogene
Segment by Type
LYS-GM101
PBGM01
AXO-AAV-GM1
Segment by Application
Type 1 GM1 Gangliosidosis
Type 2 GM1 Gangliosidosis
Type 3 GM1 Gangliosidosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GM1 Gangliosidosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global GM1 Gangliosidosis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 LYS-GM101
1.2.3 PBGM01
1.2.4 AXO-AAV-GM1
1.3 Market by Application
1.3.1 Global GM1 Gangliosidosis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Type 1 GM1 Gangliosidosis
1.3.3 Type 2 GM1 Gangliosidosis
1.3.4 Type 3 GM1 Gangliosidosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global GM1 Gangliosidosis Treatment Market Perspective (2019-2030)
2.2 GM1 Gangliosidosis Treatment Growth Trends by Region
2.2.1 Global GM1 Gangliosidosis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 GM1 Gangliosidosis Treatment Historic Market Size by Region (2019-2024)
2.2.3 GM1 Gangliosidosis Treatment Forecasted Market Size by Region (2025-2030)
2.3 GM1 Gangliosidosis Treatment Market Dynamics
2.3.1 GM1 Gangliosidosis Treatment Industry Trends
2.3.2 GM1 Gangliosidosis Treatment Market Drivers
2.3.3 GM1 Gangliosidosis Treatment Market Challenges
2.3.4 GM1 Gangliosidosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top GM1 Gangliosidosis Treatment Players by Revenue
3.1.1 Global Top GM1 Gangliosidosis Treatment Players by Revenue (2019-2024)
3.1.2 Global GM1 Gangliosidosis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global GM1 Gangliosidosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by GM1 Gangliosidosis Treatment Revenue
3.4 Global GM1 Gangliosidosis Treatment Market Concentration Ratio
3.4.1 Global GM1 Gangliosidosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by GM1 Gangliosidosis Treatment Revenue in 2023
3.5 GM1 Gangliosidosis Treatment Key Players Head office and Area Served
3.6 Key Players GM1 Gangliosidosis Treatment Product Solution and Service
3.7 Date of Enter into GM1 Gangliosidosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 GM1 Gangliosidosis Treatment Breakdown Data by Type
4.1 Global GM1 Gangliosidosis Treatment Historic Market Size by Type (2019-2024)
4.2 Global GM1 Gangliosidosis Treatment Forecasted Market Size by Type (2025-2030)
5 GM1 Gangliosidosis Treatment Breakdown Data by Application
5.1 Global GM1 Gangliosidosis Treatment Historic Market Size by Application (2019-2024)
5.2 Global GM1 Gangliosidosis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America GM1 Gangliosidosis Treatment Market Size (2019-2030)
6.2 North America GM1 Gangliosidosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America GM1 Gangliosidosis Treatment Market Size by Country (2019-2024)
6.4 North America GM1 Gangliosidosis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe GM1 Gangliosidosis Treatment Market Size (2019-2030)
7.2 Europe GM1 Gangliosidosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe GM1 Gangliosidosis Treatment Market Size by Country (2019-2024)
7.4 Europe GM1 Gangliosidosis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific GM1 Gangliosidosis Treatment Market Size (2019-2030)
8.2 Asia-Pacific GM1 Gangliosidosis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific GM1 Gangliosidosis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific GM1 Gangliosidosis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America GM1 Gangliosidosis Treatment Market Size (2019-2030)
9.2 Latin America GM1 Gangliosidosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America GM1 Gangliosidosis Treatment Market Size by Country (2019-2024)
9.4 Latin America GM1 Gangliosidosis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa GM1 Gangliosidosis Treatment Market Size (2019-2030)
10.2 Middle East & Africa GM1 Gangliosidosis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Axovant Gene Therapies Ltd
11.1.1 Axovant Gene Therapies Ltd Company Detail
11.1.2 Axovant Gene Therapies Ltd Business Overview
11.1.3 Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Introduction
11.1.4 Axovant Gene Therapies Ltd Revenue in GM1 Gangliosidosis Treatment Business (2019-2024)
11.1.5 Axovant Gene Therapies Ltd Recent Development
11.2 Passage Bio and Lysogene
11.2.1 Passage Bio and Lysogene Company Detail
11.2.2 Passage Bio and Lysogene Business Overview
11.2.3 Passage Bio and Lysogene GM1 Gangliosidosis Treatment Introduction
11.2.4 Passage Bio and Lysogene Revenue in GM1 Gangliosidosis Treatment Business (2019-2024)
11.2.5 Passage Bio and Lysogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global GM1 Gangliosidosis Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of LYS-GM101
Table 3. Key Players of PBGM01
Table 4. Key Players of AXO-AAV-GM1
Table 5. Global GM1 Gangliosidosis Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global GM1 Gangliosidosis Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global GM1 Gangliosidosis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global GM1 Gangliosidosis Treatment Market Share by Region (2019-2024)
Table 9. Global GM1 Gangliosidosis Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global GM1 Gangliosidosis Treatment Market Share by Region (2025-2030)
Table 11. GM1 Gangliosidosis Treatment Market Trends
Table 12. GM1 Gangliosidosis Treatment Market Drivers
Table 13. GM1 Gangliosidosis Treatment Market Challenges
Table 14. GM1 Gangliosidosis Treatment Market Restraints
Table 15. Global GM1 Gangliosidosis Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global GM1 Gangliosidosis Treatment Market Share by Players (2019-2024)
Table 17. Global Top GM1 Gangliosidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GM1 Gangliosidosis Treatment as of 2023)
Table 18. Ranking of Global Top GM1 Gangliosidosis Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by GM1 Gangliosidosis Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players GM1 Gangliosidosis Treatment Product Solution and Service
Table 22. Date of Enter into GM1 Gangliosidosis Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global GM1 Gangliosidosis Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global GM1 Gangliosidosis Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global GM1 Gangliosidosis Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global GM1 Gangliosidosis Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global GM1 Gangliosidosis Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global GM1 Gangliosidosis Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America GM1 Gangliosidosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America GM1 Gangliosidosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America GM1 Gangliosidosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe GM1 Gangliosidosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe GM1 Gangliosidosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe GM1 Gangliosidosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific GM1 Gangliosidosis Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific GM1 Gangliosidosis Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific GM1 Gangliosidosis Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America GM1 Gangliosidosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America GM1 Gangliosidosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America GM1 Gangliosidosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa GM1 Gangliosidosis Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa GM1 Gangliosidosis Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Axovant Gene Therapies Ltd Company Detail
Table 48. Axovant Gene Therapies Ltd Business Overview
Table 49. Axovant Gene Therapies Ltd GM1 Gangliosidosis Treatment Product
Table 50. Axovant Gene Therapies Ltd Revenue in GM1 Gangliosidosis Treatment Business (2019-2024) & (US$ Million)
Table 51. Axovant Gene Therapies Ltd Recent Development
Table 52. Passage Bio and Lysogene Company Detail
Table 53. Passage Bio and Lysogene Business Overview
Table 54. Passage Bio and Lysogene GM1 Gangliosidosis Treatment Product
Table 55. Passage Bio and Lysogene Revenue in GM1 Gangliosidosis Treatment Business (2019-2024) & (US$ Million)
Table 56. Passage Bio and Lysogene Recent Development
Table 57. Research Programs/Design for This Report
Table 58. Key Data Information from Secondary Sources
Table 59. Key Data Information from Primary Sources
List of Figures
Figure 1. Global GM1 Gangliosidosis Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global GM1 Gangliosidosis Treatment Market Share by Type: 2023 VS 2030
Figure 3. LYS-GM101 Features
Figure 4. PBGM01 Features
Figure 5. AXO-AAV-GM1 Features
Figure 6. Global GM1 Gangliosidosis Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global GM1 Gangliosidosis Treatment Market Share by Application: 2023 VS 2030
Figure 8. Type 1 GM1 Gangliosidosis Case Studies
Figure 9. Type 2 GM1 Gangliosidosis Case Studies
Figure 10. Type 3 GM1 Gangliosidosis Case Studies
Figure 11. GM1 Gangliosidosis Treatment Report Years Considered
Figure 12. Global GM1 Gangliosidosis Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global GM1 Gangliosidosis Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global GM1 Gangliosidosis Treatment Market Share by Region: 2023 VS 2030
Figure 15. Global GM1 Gangliosidosis Treatment Market Share by Players in 2023
Figure 16. Global Top GM1 Gangliosidosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GM1 Gangliosidosis Treatment as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by GM1 Gangliosidosis Treatment Revenue in 2023
Figure 18. North America GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America GM1 Gangliosidosis Treatment Market Share by Country (2019-2030)
Figure 20. United States GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe GM1 Gangliosidosis Treatment Market Share by Country (2019-2030)
Figure 24. Germany GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific GM1 Gangliosidosis Treatment Market Share by Region (2019-2030)
Figure 32. China GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America GM1 Gangliosidosis Treatment Market Share by Country (2019-2030)
Figure 40. Mexico GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa GM1 Gangliosidosis Treatment Market Share by Country (2019-2030)
Figure 44. Turkey GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia GM1 Gangliosidosis Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Axovant Gene Therapies Ltd Revenue Growth Rate in GM1 Gangliosidosis Treatment Business (2019-2024)
Figure 47. Passage Bio and Lysogene Revenue Growth Rate in GM1 Gangliosidosis Treatment Business (2019-2024)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Latest Life Science Market Reports

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock